Results 261 to 270 of about 855,465 (305)

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses. [PDF]

Diabetes Obes Metab
Cherney DZI, Rossing P, Canziani ME, Caramori ML, Correa-Rotter R, Cronin L, Hugo C, Ji B, Meyerhoff J, Nangaku M, Silva A, Urbach D, Shah SV, de Zeeuw D, Tuttle KR.   +14 more
europepmc   +1 more source

The triglyceride-glucose index in chronic kidney disease: a narrative review. [PDF]

Front Nutr
Wang Y, Wang Y, Ge Y, He X, Li X.
europepmc   +1 more source

Clinical Decision Support for Chronic Kidney Disease in Primary Care: A Cluster Randomized Clinical Trial.

JAMA Netw Open
Zheng X, Hui M, Yang H, Yang Z, Tang L, Zhao Y, Xu L, Zhou Q, Wang J, Li M, Zhu S, Gao F, Li J, Lv J, Yang L.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[Chronic Kidney Disease].

Deutsche medizinische Wochenschrift (1946), 2012
Chronic kidney disease is a general term for heterogeneous disorders affecting kidney structure and function. The 2002 guidelines for definition and classification of this disease represented an important shift towards its recognition as a worldwide public health problem that should be managed in its early stages by general internists.
M, Ketteler, C, Wanner
openaire   +5 more sources